Avantor Operating Income 2018-2025 | AVTR

Avantor annual/quarterly operating income history and growth rate from 2018 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Avantor operating income for the quarter ending March 31, 2025 was $0.147B, a 0.75% increase year-over-year.
  • Avantor operating income for the twelve months ending March 31, 2025 was $1.086B, a 77.58% increase year-over-year.
  • Avantor annual operating income for 2024 was $1.085B, a 55.77% increase from 2023.
  • Avantor annual operating income for 2023 was $0.696B, a 38.38% decline from 2022.
  • Avantor annual operating income for 2022 was $1.13B, a 16.25% increase from 2021.
Avantor Annual Operating Income
(Millions of US $)
2024 $1,085
2023 $696
2022 $1,130
2021 $972
2020 $707
2019 $552
2018 $414
2017 $-210
Avantor Quarterly Operating Income
(Millions of US $)
2025-03-31 $147
2024-12-31 $638
2024-09-30 $125
2024-06-30 $176
2024-03-31 $146
2023-12-31 $183
2023-09-30 $210
2023-06-30 $72
2023-03-31 $231
2022-12-31 $252
2022-09-30 $276
2022-06-30 $296
2022-03-31 $307
2021-12-31 $214
2021-09-30 $237
2021-06-30 $255
2021-03-31 $266
2020-12-31 $205
2020-09-30 $177
2020-06-30 $167
2020-03-31 $158
2019-12-31 $152
2019-09-30 $143
2019-06-30 $119
2019-03-31 $138
2018-12-31
2018-09-30 $132
2018-06-30 $94
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $9.336B $6.784B
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $147.077B 27.58
CVS Health (CVS) United States $83.011B 10.32
Elevance Health (ELV) United States $78.142B 10.08
Cencora (COR) United States $57.628B 20.05
DiDi Global (DIDIY) China $23.768B 25.25
Natera (NTRA) United States $22.306B 0.00
Labcorp Holdings (LH) United States $21.229B 17.22
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.751B 0.00
Solventum (SOLV) United States $13.128B 13.90
CochLear (CHEOY) Australia $12.788B 0.00
ICON (ICLR) Ireland $12.281B 11.42
Revvity (RVTY) United States $12.070B 20.77
Viatris (VTRS) United States $10.857B 3.73
Medpace Holdings (MEDP) United States $9.434B 25.06
Sonic Healthcare (SKHHY) Australia $8.582B 0.00
HealthEquity (HQY) United States $8.405B 36.81
Charles River Laboratories (CRL) United States $8.038B 15.75
Caris Life Sciences,�Inc (CAI) United States $6.772B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $5.024B 29.58
BrightSpring Health Services (BTSG) United States $3.667B 33.65
Sotera Health (SHC) United States $3.375B 19.18
Surgery Partners (SGRY) United States $2.855B 37.12
Alignment Healthcare (ALHC) United States $2.647B 0.00
Concentras Parent (CON) United States $2.621B 15.15
Organon (OGN) United States $2.605B 2.77
GeneDx Holdings (WGS) United States $2.480B 95.51
Ardent Health (ARDT) United States $2.041B 8.70
Progyny (PGNY) United States $2.024B 44.55
PACS (PACS) United States $1.949B 0.00
Premier (PINC) United States $1.767B 13.41
GoodRx Holdings (GDRX) United States $1.750B 35.00
Teladoc Health (TDOC) United States $1.546B 0.00
Establishment Labs Holdings (ESTA) $1.329B 0.00
Pediatrix Medical (MD) United States $1.160B 8.82
CareDx (CDNA) United States $1.149B 17.94
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.956B 0.00
AMN Healthcare Services Inc (AMN) United States $0.846B 7.92
QDM (QDMI) Hong Kong, SAR China $0.846B 290.00
Nutex Health (NUTX) United States $0.653B 9.89
Embecta (EMBC) United States $0.627B 4.22
InnovAge Holding (INNV) United States $0.567B 0.00
SBC Medicals (SBC) United States $0.552B 0.00
LifeMD (LFMD) United States $0.544B 0.00
Sonida Senior Living (SNDA) United States $0.486B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.60
Omada Health (OMDA) $0.461B 0.00
So-Young (SY) China $0.389B 0.00
Enhabit (EHAB) United States $0.375B 30.88
COMPASS Pathways (CMPS) United Kingdom $0.348B 0.00
Performant Healthcare (PHLT) United States $0.338B 0.00
Beauty Health (SKIN) United States $0.257B 0.00
Oncology Institute (TOI) United States $0.256B 0.00
DocGo (DCGO) United States $0.153B 25.00
Pheton Holdings (PTHL) China $0.134B 0.00
Sera Prognostics (SERA) United States $0.104B 0.00
KindlyMD (NAKA) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Basel Medical Group (BMGL) Singapore $0.055B 0.00
ModivCare (MODV) United States $0.054B 0.00
Biodesix (BDSX) United States $0.045B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
OSR Holdings (OSRH) United States $0.023B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
SeaStar Medical Holding (ICU) United States $0.007B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00